fda warning bpc 157 peptide not approved safety BPC-157 Approval Status: Is It for Human Use? bpc-157 fda warning news FDA

It is derived from a protective compound found in the stomach and has been studied for its potential to support tissue repair and inflammation regulation

Self-administration without clinical oversight removes the safety layer that makes the protocol viable

They might suggest a blood panel at the outset of treatment and then again after treatment has commenced for supplementation

GHK-Cu followed a similar path, removed from Category 2 on the same date, but its PCAC review isn't scheduled until before February 2027

Think of it as a two-part journey: a powerful initial push, followed by a steady, long-term cruise

CJC-1295 without DAC: Timing matters significantly